W DAY: Open Payments
NPI 1174591796 · GRANVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 42 payments from 14 companies in 2025. Trend: 2023 $636 · 2024 $1,550 · 2025 $841
Food & beverage: $841
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $144 |
| Novo Nordisk Inc | 8 | $143 |
| Lilly USA, LLC | 5 | $100 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| GlaxoSmithKline, LLC. | 4 | $80 |
| Lundbeck LLC | 2 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $58 |
| Alnylam Pharmaceuticals Inc. | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 3 | $37 |
| Abbott Laboratories | 1 | $21 |
Products named: REXULTI, ZEPBOUND, AIRSUPRA, GIVLAARI, SHINGRIX, TRELEGY ELLIPTA, Ozempic, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
